| Peggy Sue Haselow, PHARMD | |
|
211 W 4th St, Duluth, MN 55806-2719 | |
| (218) 726-1370 | |
| (218) 726-0501 |
| Full Name | Peggy Sue Haselow |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 211 W 4th St, Duluth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083602809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 116852-7 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peggy Sue Haselow, PHARMD Po Box 442, Beaver Bay, MN 55601-0442 Ph: (218) 226-4905 | Peggy Sue Haselow, PHARMD 211 W 4th St, Duluth, MN 55806-2719 Ph: (218) 726-1370 |
News Archive
Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas - the "Kissing Bug" disease - is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal.
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
Patients dealing with infertility face many uncertainties, but now there is one place to find a comprehensive guide to almost every aspect of infertility treatment.
In a paper published this week in the premier open-access global health journal PLoS Medicine, Majid Ezzati and colleagues from Harvard School of Public Health conclude that a large proportion of the world's population who live in low-income and middle-income countries should be the focus for intervention against risk factors for cardiovascular disease because major cardiovascular risk factors will increasingly be concentrated in these populations.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the ROI-A Oblique ALIF cage. The oblique cage complements its forerunner, the ROI-A ALIF cage, which is designed for direct anterior insertion.
› Verified 1 days ago
Jordan Tichenor, Pharmacist Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-3737 Fax: 187-278-3282 | |
Donald P Gibson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1502 London Road, Suite 101, Duluth, MN 55812 Phone: 218-733-1110 Fax: 218-733-1112 | |
Stephanie Jo Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 W 4th St, Duluth, MN 55806 Phone: 218-249-4150 Fax: 218-279-4007 | |
Dr. David Michael Malenowski I, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 Miller Trunk Hwy, Duluth, MN 55811 Phone: 218-727-8157 Fax: 218-727-4261 | |
Anthony Richard Grand, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5555 | |
Dr. Karen Ms Bastianelli, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1208 Kirby Dr, 380 Kirby Plaza, Duluth, MN 55812 Phone: 218-726-6026 Fax: 218-726-6500 | |
Michael Kozlovski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 Miller Trunk Hwy, Duluth, MN 55811 Phone: 218-727-8157 Fax: 218-727-4261 |